Sky Oak Wealth, LLC Neurocrine Biosciences Inc Transaction History

Sky Oak Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 03, 2020	SELL	$96.16 - $135.15 $192,320 - $270,300	-2,000 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$85.09 - $130.36 $170,180 - $260,720	2,000 New	2,000 $244,000
Q1 2020 May 04, 2020	SELL	$75.11 - $113.76 $183,869 - $278,484	-2,448 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$86.8 - $118.57 $212,486 - $290,259	2,448 New	2,448 $263,000

652

96.5M

282K

281K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $10.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Sky Oak Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Sky Oak Wealth, LLC with notifications on news.